Dr. Martens (LON:DOCS) Shares Down 11.6% – Here’s What Happened

Shares of Dr. Martens plc (LON:DOCS) were down 11.6% on Tuesday . The company traded as low as GBX 65 and last traded at GBX 66.90. Approximately 9,032,986 shares changed hands during trading, an increase of 342% from the average daily volume of 2,043,681 shares. The stock had previously closed at GBX 75.65.

Key Stories Impacting Dr. Martens

Here are the key news stories impacting Dr. Martens this week:

• Positive Sentiment: Berenberg Bank reaffirmed a “buy” rating on DOCS, which supports investor confidence in the brand and long-term growth potential. Broker Rating
• Negative Sentiment: Dr. Martens projected flat revenue for 2026 while saying it will scale back discounts — a move that should help margins but signals limited top-line growth near term, which is weighing on the share price. Revenue Guidance Article

Analyst Ratings Changes

DOCS has been the topic of a number of research reports. Berenberg Bank reiterated a “buy” rating on shares of Dr. Martens in a research report on Tuesday. Peel Hunt restated a “buy” rating on shares of Dr. Martens in a research report on Thursday, November 20th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of GBX 6,000.

Dr. Martens Trading Down 11.6%

The business has a 50 day simple moving average of GBX 76.53 and a 200-day simple moving average of GBX 83.47. The stock has a market capitalization of £646.63 million, a price-to-earnings ratio of 39.35, a PEG ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.

Dr. Martens (LON:DOCS) last issued its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, equities analysts expect that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Insider Activity

In other Dr. Martens news, insider Robert Hanson bought 96,000 shares of Dr. Martens stock in a transaction dated Friday, December 5th. The stock was bought at an average cost of GBX 79 per share, for a total transaction of £75,840. Over the last quarter, insiders have bought 97,130 shares of company stock valued at $7,673,816. 2.79% of the stock is currently owned by corporate insiders.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.